fusidic acid has been researched along with trovafloxacin in 1 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (trovafloxacin) | Trials (trovafloxacin) | Recent Studies (post-2010) (trovafloxacin) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 466 | 47 | 43 |
| Protein | Taxonomy | fusidic acid (IC50) | trovafloxacin (IC50) |
|---|---|---|---|
| Thromboxane-A synthase | Homo sapiens (human) | 4.023 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
1 other study(ies) available for fusidic acid and trovafloxacin
| Article | Year |
|---|---|
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |